Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eberhard L Renner

Showing results (31-40 of 65) with videos related to

Pageof 7
Sort By:
Transplantation|September 26, 2003
Living donor liver transplantation and tolerance: a potential strategy in cholangiocarcinomaZakiyah Kadry, Beat Mullhaupt, Eberhard L Renner, et al.
Critical Care Research and Practice|April 30, 2011
Thromboelastography to monitor clotting/bleeding complications in patients treated with the molecular adsorbent recirculating systemEsther B Bachli, Jörg Bösiger, Markus Béchir, et al.
Transplantation|November 26, 2009
Antiviral treatment of recurrent hepatitis C after liver transplantation: predictors of response and long-term outcomeNazia Selzner, Eberhard L Renner, Markus Selzner, et al.
Annals of Hepatology|August 26, 2014
Protease inhibitor-based triple therapy is highly effective for hepatitis C recurrence after liver transplant: a multicenter experienceNabiha Faisal, Eric M Yoshida, Marc Bilodeau, et al.
Swiss Medical Weekly|November 20, 2003
Twenty-four vs. forty-eight weeks of re-therapy with interferon alpha 2b and ribavirin in interferon alpha monotherapy relapsers with chronic hepatitis CBarbara S E August-Jörg, Jan Borovicka, Jean-François Dufour, et al.
Annals of Surgery|October 28, 2009
Live donor liver transplantation in high MELD score recipientsMarkus Selzner, Arash Kashfi, Mark S Cattral, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|November 18, 2006
Recurrent hepatitis C post-transplantation: where are we now and where do we go from here? A report from the Canadian transplant hepatology workshopKymberly D S Watt, Kelly Burak, Marc Deschênes, et al.
Hepatology (Baltimore, Md.)|February 5, 2002
Interferon and amantadine in naive chronic hepatitis C: a double-blind, randomized, placebo-controlled trialBeat Helbling, Ivan Stamenic, Francesco Viani, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|October 31, 2009
Financial, vocational, and interpersonal impact of living liver donationSusan Holtzman, Lesley Adcock, Derek A Dubay, et al.
Transplantation|May 18, 2011
Comparison of hospitalized solid organ transplant recipients and nonimmunocompromised patients with pandemic H1N1 infection: a retrospective cohort studyBrian J Minnema, Mehul Patel, Coleman Rotstein, et al.
Pageof 7

Showing results (31-40 of 65) with videos related to

Sort By:
Pageof 7
Transplantation|September 26, 2003
Living donor liver transplantation and tolerance: a potential strategy in cholangiocarcinomaZakiyah Kadry, Beat Mullhaupt, Eberhard L Renner, et al.
Critical Care Research and Practice|April 30, 2011
Thromboelastography to monitor clotting/bleeding complications in patients treated with the molecular adsorbent recirculating systemEsther B Bachli, Jörg Bösiger, Markus Béchir, et al.
Transplantation|November 26, 2009
Antiviral treatment of recurrent hepatitis C after liver transplantation: predictors of response and long-term outcomeNazia Selzner, Eberhard L Renner, Markus Selzner, et al.
Annals of Hepatology|August 26, 2014
Protease inhibitor-based triple therapy is highly effective for hepatitis C recurrence after liver transplant: a multicenter experienceNabiha Faisal, Eric M Yoshida, Marc Bilodeau, et al.
Swiss Medical Weekly|November 20, 2003
Twenty-four vs. forty-eight weeks of re-therapy with interferon alpha 2b and ribavirin in interferon alpha monotherapy relapsers with chronic hepatitis CBarbara S E August-Jörg, Jan Borovicka, Jean-François Dufour, et al.
Annals of Surgery|October 28, 2009
Live donor liver transplantation in high MELD score recipientsMarkus Selzner, Arash Kashfi, Mark S Cattral, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|November 18, 2006
Recurrent hepatitis C post-transplantation: where are we now and where do we go from here? A report from the Canadian transplant hepatology workshopKymberly D S Watt, Kelly Burak, Marc Deschênes, et al.
Hepatology (Baltimore, Md.)|February 5, 2002
Interferon and amantadine in naive chronic hepatitis C: a double-blind, randomized, placebo-controlled trialBeat Helbling, Ivan Stamenic, Francesco Viani, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|October 31, 2009
Financial, vocational, and interpersonal impact of living liver donationSusan Holtzman, Lesley Adcock, Derek A Dubay, et al.
Transplantation|May 18, 2011
Comparison of hospitalized solid organ transplant recipients and nonimmunocompromised patients with pandemic H1N1 infection: a retrospective cohort studyBrian J Minnema, Mehul Patel, Coleman Rotstein, et al.
Pageof 7